Masonic Cancer Center, University of Minnesota clinical trial pipeline

5 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 3 with minor changes only.

1. Notable

   MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed…MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma

   Primary completion pushed from Sep 1, 2026 to Sep 1, 2027

   Also in this update: Study completion pushed from Sep 1, 2027 to Sep 1, 2028

   Masonic Cancer Center, University of Minnesota·Phase 2· NCT06377540· Registry history of NCT06377540 on ClinicalTrials.gov (opens the registry)

   Sep 29, 2026

2. Notable

   Kava on Anxiety and Stress in Cancer Survivors

   Reclassified as withdrawn (was terminated)

   And 1 more change in the last 30 days

   Masonic Cancer Center, University of Minnesota·Early Phase 1· NCT06213298· Registry history of NCT06213298 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.